A*STAR
GenomeFrontier is collaborating with A*STAR in Singapore to develop multiplex 4th-generation CAR-T therapy for treatment of epithelial solid cancers (transgene size >7kb)
A*STAR
GenomeFrontier is collaborating with A*STAR in Singapore to develop multiplex 4th-generation CAR-T therapy for treatment of epithelial solid cancers (transgene size >7kb)